CN105886645A - Primer, probe and kit for evaluating anti-wrinkle condition of skin - Google Patents
Primer, probe and kit for evaluating anti-wrinkle condition of skin Download PDFInfo
- Publication number
- CN105886645A CN105886645A CN201610367685.2A CN201610367685A CN105886645A CN 105886645 A CN105886645 A CN 105886645A CN 201610367685 A CN201610367685 A CN 201610367685A CN 105886645 A CN105886645 A CN 105886645A
- Authority
- CN
- China
- Prior art keywords
- skin
- seq
- gene
- snp site
- wrinkle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000523 sample Substances 0.000 title claims abstract description 27
- 230000001153 anti-wrinkle effect Effects 0.000 title abstract description 4
- 230000037303 wrinkles Effects 0.000 claims abstract description 59
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 27
- 206010040954 Skin wrinkling Diseases 0.000 claims description 81
- 210000003491 skin Anatomy 0.000 claims description 77
- 238000012360 testing method Methods 0.000 claims description 23
- 230000006378 damage Effects 0.000 claims description 13
- 230000003796 beauty Effects 0.000 claims description 10
- 230000037394 skin elasticity Effects 0.000 claims description 10
- 102000008186 Collagen Human genes 0.000 claims description 9
- 108010035532 Collagen Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 101000921280 Homo sapiens EMILIN-1 Proteins 0.000 claims description 8
- 238000004364 calculation method Methods 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- 230000032683 aging Effects 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 7
- 230000035772 mutation Effects 0.000 claims description 7
- 238000012217 deletion Methods 0.000 claims description 6
- 230000037430 deletion Effects 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 6
- 102200118305 rs2071307 Human genes 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 208000031481 Pathologic Constriction Diseases 0.000 claims description 4
- 210000004207 dermis Anatomy 0.000 claims description 4
- 210000004177 elastic tissue Anatomy 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 210000001215 vagina Anatomy 0.000 claims description 4
- 108010069502 Collagen Type III Proteins 0.000 claims description 3
- 102000001187 Collagen Type III Human genes 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 208000027418 Wounds and injury Diseases 0.000 claims description 3
- 230000001717 pathogenic effect Effects 0.000 claims description 3
- 208000014674 injury Diseases 0.000 claims description 2
- 230000004952 protein activity Effects 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000007850 fluorescent dye Substances 0.000 description 23
- 239000000243 solution Substances 0.000 description 14
- 210000003296 saliva Anatomy 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 9
- 102100033167 Elastin Human genes 0.000 description 8
- 102100028314 Filaggrin Human genes 0.000 description 8
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 8
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 8
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 7
- 102100032059 EMILIN-1 Human genes 0.000 description 6
- 101000990915 Homo sapiens Stromelysin-1 Proteins 0.000 description 6
- 102100030416 Stromelysin-1 Human genes 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 102100031611 Collagen alpha-1(III) chain Human genes 0.000 description 5
- 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000009514 concussion Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000009456 molecular mechanism Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 2
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical class CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000013139 quantization Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000037075 skin appearance Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 102100031786 Adiponectin Human genes 0.000 description 1
- 108010072151 Agouti Signaling Protein Proteins 0.000 description 1
- 102100038154 Agouti-signaling protein Human genes 0.000 description 1
- 240000001789 Carlina acaulis Species 0.000 description 1
- 235000005882 Carlina acaulis Nutrition 0.000 description 1
- 101150008975 Col3a1 gene Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101150108568 ELN gene Proteins 0.000 description 1
- 102100025403 Epoxide hydrolase 1 Human genes 0.000 description 1
- 101150063233 FLG gene Proteins 0.000 description 1
- 102100030943 Glutathione S-transferase P Human genes 0.000 description 1
- 101000775469 Homo sapiens Adiponectin Proteins 0.000 description 1
- 101001077852 Homo sapiens Epoxide hydrolase 1 Proteins 0.000 description 1
- 101001010139 Homo sapiens Glutathione S-transferase P Proteins 0.000 description 1
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 description 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
- 101000616738 Homo sapiens NAD-dependent protein deacetylase sirtuin-6 Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102100020880 Kit ligand Human genes 0.000 description 1
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
- 102100037258 Membrane-associated transporter protein Human genes 0.000 description 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
- 102100021840 NAD-dependent protein deacetylase sirtuin-6 Human genes 0.000 description 1
- 102100034574 P protein Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091007563 SLC45A2 Proteins 0.000 description 1
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- -1 iso-amylene isoflavone Chemical compound 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 108010045815 superoxide dismutase 2 Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a primer, probe and kit for evaluating the anti-wrinkle condition of skin. The sequences of the primer and the probe are SEQ ID NO:1-4, SED ID NO:5-8, SEQ ID NO:9-12, SEQ ID NO:13-15, SEQ ID NO:16-18, SEQ ID NO:19-21 and SEQ ID NO:22-25 wherein the 5' ends and the 3'ends of SEQ ID NO:3-4, SEQ ID NO:7-8, SEQ ID NO:11-12, SEQ ID NO:15, SEQ ID NO:18, SEQ ID NO:21 and SEQ ID NO: 24-25 are connected with different fluorescence markers respectively. The invention further discloses a method for assisting a user in selecting a correct beautifying method through gene detection. The internal cause and the external cause of wrinkles of skin of a customer are leant, a user-friendly beautifying healthy solution is provided, and the effects of anti-wrinkle beautifying products are maximized.
Description
Technical field
The present invention relates to beauty treatment fields, particularly relate to a kind of primer for assessing skin wrinkle resisting situation and probe and reagent
Box.
Background technology
SNP (single nucleotide polymorphism) refers to the variation of single core thuja acid on genome, including conversion, transversion, disappearance
And insertion, it is a kind of modal genetic marker, the frequency of carrying in crowd is more than 1%, is widely used in human diseases and examines
The fields such as disconnected, medicine individuation use, Basic of Biology research.Along with different SNP site researchs are goed deep into, by multiple
The combine detection of SNP site and follow-up data analysis, can formulate personalized health for the gene information of different crowd
Solution.
The skin appearance of human body is affected by endogenous cause of ill and exopathogenic factor, and exopathogenic factor includes that ultraviolet, environmental pollution, improper beauty treatment are produced
Product use etc., endogenous cause of ill is then embodied in the Biochemical changes relevant to skin, including protein active, hormone level etc., these changes
Mostly determined by gene.Mostly the skin care method of present stage is to take according to exopathogenic factor, as used sunscreen cream, guarantor
Humectant etc., but these have little effect mostly without maintenance method targetedly, cure the symptoms, not the disease.Along with growth in the living standard,
Increasing for improving the demand of skin smooth and tautness, carrying out specific aim beauty and skin care in conjunction with internal and external reasons will ratio tradition side
Method more advantage, the most accurately understands endogenous cause of ill and seems most important.
Be there is again multiple SNP site by multiple effect genes, each gene in the generation of wrinkle of skin, these sites can shadow
Ring the enzymatic activity of related gene.The skin wrinkle resisting ability that can evaluate and test Different Individual is detected, also by the SNP site of related gene
Can assess whether relevant cosmetics are applicable to tester, make product effect reach to maximize, combine daily on this basis
Living habit adjusts, and makes cosmetic result promote further.For this detection method, choose Sites Combination and follow-up accurately
Data analysis is particularly important.Having patent/Patent Application Publication report both at home and abroad utilizes SNP site genotype to judge cosmetics
It is suitable for skin type, but there are still susceptible SNP site and choose inaccurate, testing result the most energetic total score analysis problem.When
Before have no combine different genes SNP site combine detection and quantization algorithm assessment skin wrinkle resisting ability report.
Chinese utility model patent 201320009798.7 discloses a kind of gene chip, utilizes this genechip detection beautiful
White and aging related gene SNP site, the SNP site of whitening gene includes SLC45A2 (re35391), KITLG
(rs642742)、ASIP(rs1015362)、TYR(rs1042602)、OCA2(rs1800414)、DCT(rs2031526)、MC1R
(rs885479), the SNP of aging gene include MMP1 (rs1799750), TIMP1 (rs4898), SIRT6 (rs107251),
SOD2 (rs4880), NQO1 (rs1800566), TNFA (rs1800629), EPHX (rs1051740), but the base that this patent uses
Because chip method is cumbersome, it is difficult to be suitable for a large amount of detection.Chinese invention patent application 201180056031.3 has screened one group
The gene (LPL, ADIPOQ, PLN etc.) relevant to skin aging, and according to this group genescreen to a kind of aging resistance new material,
Not mentioned gene-correlation SNP site in this patent application.Chinese patent application 201080044917.1 provides one and utilizes sky
So antisense polynucleotides or compound are used for regulating and controlling FLG gene expression, thus reach prevention or treat the disease relevant to FLG.
United States Patent (USP) US200812286033 induces related gene expression to reach to improve wrinkle by Monoterpenes
Effect.United States Patent (USP) US200912512368 induces ELN and COL3A1 gene by the cosmetics containing iso-amylene isoflavone
Express, thus reach to improve the effect of skin appearance.United States Patent (USP) US201514618080 and US201313932565 pass through
Skin aging position uses Carlina acaulis extract and olive oil extract, makes the related gene including ELN and COL3A1 be subject to
To regulation and control up-regulated expression, thus reach to improve effect of ageing skin.
Above patent/patent application all utilize foreign substance to regulate and control the intragentic expression of body, but the gene of each individuality
In but there are differences SNP site, this method is difficult to reach personalized maintenance or treatment.British patent GB20110021917 is examined
Survey the target gene SNP site relevant to cosmetics ingredients Biogenic approach, and then judged whether this product is suitable for use with
Person, the SNP site that this patent relates to has MMP-1 (rs1799750), NQO1 (rs1800566), GSTP1 (rs1695), hGPX1
(rs10504)。
Summary of the invention
It is an object of the invention to provide a kind of primer for assessing skin wrinkle resisting situation and probe.
For achieving the above object, the present invention provides a kind of primer for assessing skin wrinkle resisting situation and probe, its feature
It is, described sequence such as SEQ ID NO:1-4, and SEQ ID NO:5-8, and SEQ ID NO:9-12, and SEQ ID NO:13-
15, and SEQ ID NO:16-18, and SEQ ID NO:19-21, and SEQ ID NO:22-25；Wherein SEQ ID NO:3-4,7-
5 ' the ends of 8,11-12,15,18,21,24-25 connect different fluorescent labelinies respectively with 3 ' ends.
The present invention also provides for a kind of test kit for assessing skin wrinkle resisting situation, it is characterised in that draw containing described
Thing and probe.
The present invention also provides for a kind of method utilizing the gene test auxiliary correct beauty method of customer selecting, and its feature exists
In, use described primer and probe, or the test kit described in use
Further, step is:
1) use described in primer and probe or described test kit client is carried out SNP site detection；
2) the skin wrinkle resisting ability value of client is gone out according to susceptible SNP site combination calculation；Described susceptible SNP site is combined as
ELNrs2071307、EMILIN1rs2011616、FLGrs146466242、rs200519781、MMP3rs3025058、
MMP1rs1799750、COL3A1rs1800255；
3) combine 1) SNP site testing result and 2) skin wrinkle resisting ability value, carry out result judgement.
Further, described step 1) be,
Extract the DNA sample of client；
Described primer and probe or described test kit is used to carry out PCR amplification；Preferably, the response procedures of PCR amplification is
50 DEG C of 2min, 95 DEG C of 10min, 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.
Further, described step 2) be,
The pathogenic risk ratio ratio of each loci gene type according to the combination of known susceptible SNP site calculates integrated risk
Odds ratio OR (C), calculation equation is:
Produce average risk ratio odds (D) by known Chinese population different age group wrinkle of skin, calculate detection
Individual wrinkle of skin produces value-at-risk ratio odds (X), and calculating formula is odds (X)=OR (C) × odds (D)；
Calculate integrated risk value:
According to known normal genotype crowd's value-at-risk F (N), calculate individual's skin wrinkling resistance value.
Further, described step 3) result be judged as,
1) if individual's skin wrinkling resistance value is less than 100%, then it represents that the skin wrinkle resisting ability of this individuality is less than this age
The normal value of Duan Renqun, wrinkling resistance is poor, belongs to the body constitution being easily generated wrinkle；Being worth the lowest, wrinkling resistance is the poorest；
2) if individual's skin wrinkling resistance value is equal to 100%, then it represents that the skin wrinkle resisting ability of this individuality and this age bracket
The normal value of crowd is the same, and wrinkling resistance is general；
3) if individual's skin wrinkling resistance value is higher than 100%, then it represents that the skin wrinkle resisting ability of this individuality is higher than this age
The normal value of Duan Renqun, wrinkling resistance is preferable, belongs to the body constitution being not likely to produce wrinkle；Being worth the highest, wrinkling resistance is the best；
Simultaneously；
If SNP site rs2071307 of gene ELN is A/A, show to carry homozygous mutation, weaken the elasticity of skin and draw
Stretch ability, promote chronological ageing；If A/G, show to carry heterozygous mutant, weaken elasticity and the stretch capability of skin, promote slow
Property is aging；If G/G, then it it is normal genotype；
If SNP site rs2011616 of gene EMILIN1 is A/A, show to carry homozygous mutation, but a crease in the skin risk
Normally；If A/G, showing to carry G, elastic fiber quality reduces, dermis strength reduction, easy fold；If G/G, then
For normal genotype, but owing to carrying G, elastic fiber quality reduces, dermis strength reduction, easy fold；
If SNP site rs146466242 of gene FLG is A/T, showing to carry heterozygous mutant, skin mechanical strength is more weak,
Skin is easily subject to external injury；If T/T, then it it is normal genotype；
If SNP site rs200519781 of gene FLG is T/-, being shown to be deletion Genotype, silk polymeric protein activity is relatively
Weak, the easy shallow stricture of vagina of skin is too much；If T/T, then it it is normal genotype；
If SNP site rs3025058 of gene M MP3 is-/A, being shown to be deletion Genotype, enzyme is lived and is reduced, and increases collagen
Fibre damage and the risk of destruction, skin elasticity declines；If-/-, being then deletion Genotype, enzyme is lived and is reduced, and increases collagen fine
Dimension damage and the risk destroyed, skin elasticity declines；If A/A, then it it is normal genotype；
If SNP site rs1799750 of gene M MP1 is C/C, being shown to be insertion genotype, enzyme is lived and is reduced, and increases collagen
Fibre damage and the risk of destruction, skin elasticity declines；If-/C, being shown to be insertion genotype, enzyme is lived and is reduced, and increases collagen
Fibre damage and the risk of destruction, skin elasticity declines；If-/-, then it it is normal genotype；
If SNP site rs1800255 of gene C OL3A1 is A/G, it is shown to be and carries heterozygous mutant, without relevant risk；If
For A/A, being shown to be and carry homozygous mutation, type III collagen protein weakens or disappears so that skin is more readily formed wrinkle；If
G/G, then be normal genotype.
It is clear that the present invention (1) filters out one group of molecular mechanism, can be used for the SNP position of comprehensive accurate evaluation skin wrinkle resisting ability
Point combination；(2) use high specificity, highly sensitive TaqMan-MGB Probe-detection methods to detect, can detect many simultaneously
Individual sample；(3) by algorithm precise quantification wrinkle generation risk to assess skin wrinkle resisting ability, personalization is provided for tester
Skin wrinkle resisting scheme.
The technical solution used in the present invention is: binding molecule Mechanism Study, literature search and clinical data screening, obtains one
The susceptible SNP site combination that group skin wrinkle resisting is relevant, described combination site is respectively ELN (rs2071307), EMILIN1
(rs2011616)、FLG(rs146466242、rs200519781)、MMP3(rs3025058)、MMP1(rs1799750)、
COL3A1 (rs1800255), the site information of described combination is shown in Table 1, and this combination site can be with the skin of accurate evaluation Different Individual
Skin wrinkling resistance.
Table 1 susceptible SNP site information table
In order to detect described site, applicant devises the primer needed for detection and probe, described primer and fluorescent probe
As follows (underscore is SNP site):
ELN (rs2071307) primer and fluorescent probe sequence:
EMILIN1 (rs2011616) primer and fluorescent probe sequence:
FLG (rs146466242) primer and fluorescent probe sequence:
FLG (rs200519781) primer and fluorescent probe sequence:
Forward primer GATCCTTGTCTTCGTCCAGT SEQ ID NO:13；
Reverse primer AGCAGAGCCACCAAGAGTCC SEQ ID NO:14；
Fluorescent probe VIC-TCCAGACCTTCCCCCTGACCAGT-MGB SEQ ID NO:15；
MMP3 (rs3025058) primer and fluorescent probe sequence:
Forward primer TCATATCAATGTGGCCAAATATTT SEQ ID NO:16；
Reverse primer CCTGCCTCAACCTCTCAAAGTGCT SEQ ID NO:17；
Fluorescent probe VIC-CAAGACATGGTTTTTTCCCCC-MGB SEQ ID NO:18；
MMP1 (rs1799750) primer and fluorescent probe sequence:
Forward primer TACCCTCTTGAACTCACATGTTAT SEQ ID NO:19；
Reverse primer TTACTCATAAACAATACTTCAGTA SEQ ID NO:20；
Fluorescent probe VIC-AATTAGAAAGGATATGACTTA-MGB SEQ ID NO:21；
COL3A1 (rs1800255) primer and fluorescent probe sequence:
Described loci detection method specifically comprises the following steps that
1, human saliva sample collection.Using non-injurious salivary automatically to flow out acquisition mode, before saliva gathers, 30min needs to use
Foreign material in drinking water cleaning oral cavity, collection 2mL saliva is deposited in saliva preservation liquid and (is caused kind biotechnology share purchased from Xiamen limited
Company) for detection.
2, human body complete genome DNA extracts.Use potassium iodide method, with reference to concretely comprising the following steps: take 0.1mL saliva in 1.5mL
In centrifuge tube, adding 500 μ L 0.01mol/L PBS solution and repeatedly blow and beat, 10000rpm is centrifuged 5min；Supernatant, precipitation is gone to add
50 μ L5mol/L KI solution, concussion mixing, add 100 μ L 0.9%NaCl solution, 150 μ L phenol/chloroform (25: 24, V/V)
Mixed liquor, concussion 30s, 10000rpm are centrifuged 5min；Taking 200 μ L of supernatant, add 200 μ L isopropanols, mixing, 10000rpm is centrifuged
5min；Going supernatant, precipitation to add 1mL absolute ethanol washing, 10000rpm is centrifuged 5min；Abandon dehydrated alcohol, be deposited in super-clean bench
In dry up, add 50 μ L TE buffer solution ,-20 DEG C save backup.
3, PCR reaction system and response procedures.10 μ L reaction systems containUniversal PCR Master Mix
(Applied Biosystems, Applied Biotechnology company limited of the U.S.) 5 μ L, DNA profiling 1 μ L, fluorescent probe (each SNP
The detection correspondence probe in site mixes) (2.5 μMs) and primer mixed liquor (its corresponding primer of the detection of each SNP site
Mix) 1.5 μ L, ddH2O 2.5μL.Response procedures is 50 DEG C of 2min, 95 DEG C of 10min, and 95 DEG C of 15s, 60 DEG C of 1min follow
Ring 40 times.Detecting instrument is StepOnePlus real-time fluorescence quantitative PCR instrument (Applied Biosystems, U.S.'s application biology
Technology Co., Ltd.).
4, interpretation.Use StepOnePlusTMSoftware v2.3 (Applied Biosystems, the U.S.
Applied Biotechnology company limited) it is analyzed, according to different fluorescence signals, draw the genotype of corresponding SNP site.
Skin wrinkle resisting ability quantization method is as follows: 1, wrinkle of skin produces integrated risk ratio than calculating.Known detection institute
The pathogenic risk ratio of each loci gene type obtained is than respectively OR1、OR2…ORm(literature query is learnt, the results are shown in Table 3),
Can calculate individual's skin wrinkle produce integrated risk ratio than OR (C), calculation equation is as follows:
2, the individual's skin wrinkle calculated by step 1 produces integrated risk ratio than OR (C), by document or other
Statistical approach can obtain Chinese population different age group wrinkle of skin and produce average risk ratio odds (D) (known Chinese
Group different age group wrinkle of skin produce average risk ratio odds (D) be respectively as follows: 20-35 year: 0.08,36-45 years old: 0.30,
46-55 year: 0.62), by odds ratio computing formula can calculate detection individual's skin wrinkle produce value-at-risk ratio odds
(X), calculation equation is as follows:
I.e. odds (X)=OR (C) * odds (D).
3, the individual's skin wrinkle calculated by step 2 produces risk ratio odds (X), i.e. can be pushed away by value-at-risk
Calculating formula and can calculate integrated risk value F (X), calculation equation is as follows:
4, the skin wrinkle resisting ability of Different Individual can be assessed by the calculated integrated risk value of step 3, it is known that just
Often genotype crowd's value-at-risk F (N) (known normal genotype crowd's value-at-risk F (N) be respectively as follows: 20-35 year: 7.4%, 36-45
Year: 23%, 46-55 year: 38.3%), individual's skin wrinkling resistance V can be calculated, calculation equation is as follows:
Testing result personality analysis and solution:
According to wrinkling resistance quantum chemical method result, in conjunction with function and the molecular mechanism of related locus, it is judged that skin problem
Probability, assessment tester can use the cosmetics containing which kind of composition, and adjust the daily life being conducive to skin protection for it
Dietary habit alive.The molecular mechanism of related gene is as follows: if ELN carries sudden change, then skin easily relaxes；FLG carries sudden change,
Easily cause the symptom such as dermatitis, too much, the allergy of the shallow stricture of vagina of skin；MMP1 and MMP3 carries sudden change, easily causes skin aging；
EMILIN1 carries sudden change, easily causes cutis laxa；COL3A1 carries sudden change, then type III collagen protein weakens or disappears so that
Skin is more readily formed wrinkle.
Beneficial effect: can be fully understood by endogenous cause of ill and exopathogenic factor that wrinkle of skin produces, provides the user personalized beauty care and is good for
Health solution, makes anti-wrinkle cosmetic product using effect maximize.Further, it is also possible to adjust the day being conducive to skin protection for tester
Often Diet lifestyle.
Detailed description of the invention
Embodiments of the invention are described below in detail, and the example of described embodiment is being intended to for explaining the present invention, and not
It is understood that as limitation of the present invention.In embodiment, unreceipted concrete technology or condition person, retouched according to the document in this area
The technology stated or condition or carry out according to product description.Agents useful for same or instrument unreceipted production firm person, be permissible
By city available from conventional products.
Embodiment 1: primer and probe design
1, design and synthesize following primer and probe, synthesize unit: Applied Biosystems, the U.S. applies biological skill
Art company limited.
ELN (rs2071307) primer and fluorescent probe sequence:
EMILIN1 (rs2011616) primer and fluorescent probe sequence:
FLG (rs146466242) primer and fluorescent probe sequence:
FLG (rs200519781) primer and fluorescent probe sequence:
Forward primer GATCCTTGTCTTCGTCCAGT SEQ ID NO:13；
Reverse primer AGCAGAGCCACCAAGAGTCC SEQ ID NO:14；
Fluorescent probe VIC-TCCAGACCTTCCCCCTGACCAGT-MGB SEQ ID NO:15；
MMP3 (rs3025058) primer and fluorescent probe sequence:
Forward primer TCATATCAATGTGGCCAAATATTT SEQ ID NO:16；
Reverse primer CCTGCCTCAACCTCTCAAAGTGCT SEQ ID NO:17；
Fluorescent probe VIC-CAAGACATGGTTTTTTCCCCC-MGB SEQ ID NO:18；
MMP1 (rs1799750) primer and fluorescent probe sequence:
Forward primer TACCCTCTTGAACTCACATGTTAT SEQ ID NO:19；
Reverse primer TTACTCATAAACAATACTTCAGTA SEQ ID NO:20；
Fluorescent probe VIC-AATTAGAAAGGATATGACTTA-MGB SEQ ID NO:21；
COL3A1 (rs1800255) primer and fluorescent probe sequence:
2, SNP site detection
1) sample collection.Detection sample in the present embodiment uses human saliva, and before saliva gathers, 30min need to be with drinking
Foreign material in water cleaning oral cavity, gather 2mL saliva and deposit in saliva preservation liquid (purchased from the kind limited public affairs of biotechnology share of Xiamen cause
Department) for detection.
2) human body complete genome DNA extracts.Use potassium iodide method, with reference to concretely comprising the following steps: take 0.1mL saliva in 1.5mL
In centrifuge tube, adding 500 μ L 0.01mol/L PBS solution and repeatedly blow and beat, 10000rpm is centrifuged 5min；Supernatant, precipitation is gone to add
50 μ L5mol/L KI solution, concussion mixing, add 100 μ L 0.9%NaCl solution, 150 μ L phenol/chloroform (25: 24, V/V)
Mixed liquor, concussion 30s, 10000rpm are centrifuged 5min；Taking 200 μ L of supernatant, add 200 μ L isopropanols, mixing, 10000rpm is centrifuged
5min；Going supernatant, precipitation to add 1mL absolute ethanol washing, 10000rpm is centrifuged 5min；Abandon dehydrated alcohol, be deposited in super-clean bench
In dry up, add 50 μ L TE buffer solution ,-20 DEG C save backup.
3) reaction system and response procedures: 10 μ L reaction systems containUniversal PCR Master Mix
(Applied Biosystems, Applied Biotechnology company limited of the U.S.) 5 μ L, DNA profiling 1 μ L, fluorescent probe (each SNP
The detection correspondence probe in site mixes) (2.5 μMs) and primer mixed liquor 1.5 μ L, ddH2O 2.5μL.Response procedures is
50 DEG C of 2min, 95 DEG C of 10min, 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.Detecting instrument is StepOnePlus real time fluorescent quantitative
PCR instrument (Applied Biosystems, Applied Biotechnology company limited of the U.S.).
4, after detection program end of run, StepOnePlus is usedTMSoftware v2.3(Applied
Biosystems, Applied Biotechnology company limited of the U.S.) testing result is analyzed, draw corresponding SNP genotype (see
Table 2).
Table 2SNP site testing result table
| Detection gene | SNP_ID | Genotype |
| ELN | rs2071307 | G/G |
| EMILIN1 | rs2011616 | A/A |
| FLG | rs200519781 | T/- |
| FLG | rs146466242 | T/T |
| MMP3 | rs3025058 | -/- |
| MMP1 | rs1799750 | -/C |
| COL3A1 | rs1800255 | A/G |
3, wrinkling resistance quantitative evaluation and personalized solution
1) wrinkle produces integrated risk value calculating.Being learnt by literature query, the ratio of different loci is as shown in table 3.
Risk ratio ratio (OR) table of table 3 related locus genotype
(1) individual's skin wrinkle produces integrated risk ratio than OR (C) calculating.The OR value of different loci is as shown in table 2, then
(2) calculate individual's skin wrinkle by step (1) and produce integrated risk ratio than OR (C), comprehensive literature and tune
Look into data and learn that the ratio odds (D) of Chinese population 20-35 age bracket wrinkle of skin is about 0.08 (the detection sample of the present embodiment
Belong to this age bracket, therefore select the data of this age bracket), detection individual's skin can be calculated by odds ratio computing formula and wrinkle
Stricture of vagina produces value-at-risk ratio odds (X)=OR (C) × odds (D)=10.13 × 0.08=0.81.
(3) the detection individual's skin wrinkle calculated by step (2) produces risk ratio odds (X), integrated risk value
(4) known normal genotype crowd's value-at-risk F (N) is 7.4%, can calculate skin wrinkle resisting ability value
2), testing result is comprehensively analyzed.The skin wrinkle resisting ability value of this individuality is only 16.53%, and skin wrinkle resisting ability is relatively
Difference, belongs to the body constitution being easily generated wrinkle.In combination with the molecular mechanism of related gene, as shown in Table 2 in this detection individuality
EMILIN1, MMP3 carry susceptibility loci homozygous mutation, and FLG, MMP1 carry susceptibility loci heterozygous mutant, and these sudden changes can affect
Silk polymeric protein, matrix metal proteinase activity, affect skin elasticity, it means that the skin elasticity of this individuality relatively common people
Difference, skin easily relaxes.
3), personalized solution: this individual's skin wrinkling resistance is poor, and the sudden change of multiple related genes makes this individuality
Congenital it is easily generated wrinkle, the selection of cosmetics need to be should be specifically noted that, use and can improve a polymeric protein, the change of elastin laminin activity
Cosmetic；Keeping skin clean clean, makeup removing should be thorough, reduces skin pore blocking.Note supplementing natural complex C, as western red
Fructus Kaki, Radix Dauci Sativae etc.；Optional collagen protein and the food of elastin laminin rich content, avoid eating and drinking too much at one meal；Fat-reducing of excessively going on a diet also can
Cause the too fast loss of skin-nourishing to can not get effectively supplementing, cause skin depressions to relax；Unhealthy emotion and expression can cause skin
Skin can not get effectively having a rest because overworking and formed lax.
Although above it has been shown and described that embodiments of the invention, it is to be understood that above-described embodiment is example
Property, it is impossible to be interpreted as limitation of the present invention, those of ordinary skill in the art is without departing from the principle of the present invention and objective
In the case of above-described embodiment can be changed within the scope of the invention, revise, replace and modification.
Claims (7)
1. primer and the probe being used for assessing skin wrinkle resisting situation, it is characterised in that described sequence such as SEQ ID NO:1-
4, and SEQ ID NO:1-4, and SEQ ID NO:5-8, and SEQ ID NO:9-12, and SEQ ID NO:13-15, and SEQ ID
NO:16-18, and SEQ ID NO:19-21, and SEQ ID NO:22-25；Wherein SEQ ID NO:3-4,7-8,11-12,15,
5 ' the ends of 18,21,24-25 connect different fluorescent labelinies respectively with 3 ' ends.
2. the test kit being used for assessing skin wrinkle resisting situation, it is characterised in that containing the primer described in claim 1 and spy
Pin.
3. the method utilizing the gene test auxiliary correct beauty method of customer selecting, it is characterised in that use claim 1
Primer and probe, or use claim 2 test kit.
4. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 3, it is characterised in that step
For:
1) use the primer of claim 1 and the test kit of probe or claim 2 that client is carried out SNP site detection；
2) the skin wrinkle resisting ability value of client is gone out according to susceptible SNP site combination calculation；Described susceptible SNP site is combined as
ELNrs2071307、EMILIN1rs2011616、FLGrs146466242、rs200519781、MMP3rs3025058、
MMP1rs1799750、COL3A1rs1800255；
3) combine 1) SNP site testing result and 2) skin wrinkle resisting ability value, carry out result judgement.
5. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 4, it is characterised in that described
Step 1) be,
Extract the DNA sample of client；
Test kit described in primer described in claim 1 and probe or claim 2 is used to carry out PCR amplification；Preferably, PCR expands
The response procedures increased is 50 DEG C of 2min, 95 DEG C of 10min, and 95 DEG C of 15s, 60 DEG C of 1min circulate 40 times.
6. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 4, it is characterised in that described
Step 2) be,
The pathogenic risk ratio ratio of each loci gene type according to the combination of known susceptible SNP site calculates integrated risk ratio
Ratio OR (C), calculation equation is:
Produce average risk ratio odds (D) by known Chinese population different age group wrinkle of skin, calculate detection individuality
Wrinkle of skin produce value-at-risk ratio odds (X), calculating formula is odds (X)=OR (C) × odds (D)；
Calculate integrated risk value:
According to known normal genotype crowd's value-at-risk F (N), calculate individual's skin wrinkling resistance value.
7. the method utilizing the gene test auxiliary correct beauty method of customer selecting described in claim 4, it is characterised in that described
Step 3) result be judged as,
1) if individual's skin wrinkling resistance value is less than 100%, then it represents that the skin wrinkle resisting ability of this individuality is less than this age bracket people
The normal value of group, wrinkling resistance is poor, belongs to the body constitution being easily generated wrinkle；Being worth the lowest, wrinkling resistance is the poorest；
2) if individual's skin wrinkling resistance value is equal to 100%, then it represents that the skin wrinkle resisting ability of this individuality and this age bracket crowd
Normal value the same, wrinkling resistance is general；
3) if individual's skin wrinkling resistance value is higher than 100%, then it represents that the skin wrinkle resisting ability of this individuality is higher than this age bracket people
The normal value of group, wrinkling resistance is preferable, belongs to the body constitution being not likely to produce wrinkle；Being worth the highest, wrinkling resistance is the best；
Simultaneously；
If SNP site rs2071307 of gene ELN is A/A, show to carry homozygous mutation, weaken elasticity and the stretching energy of skin
Power, promotes chronological ageing；If A/G, show to carry heterozygous mutant, weaken elasticity and the stretch capability of skin, promote chronic always
Change；If G/G, then it it is normal genotype；
If SNP site rs2011616 of gene EMILIN1 is A/A, shows to carry homozygous mutation, but a crease in the skin risk is normal；
If A/G, showing to carry G, elastic fiber quality reduces, dermis strength reduction, easy fold；If G/G, then it is normal
Genotype, but owing to carrying G, elastic fiber quality reduces, dermis strength reduction, easy fold；
If SNP site rs146466242 of gene FLG is A/T, showing to carry heterozygous mutant, skin mechanical strength is more weak, skin
It is easily subject to external injury；If T/T, then it it is normal genotype；
If SNP site rs200519781 of gene FLG is T/-, being shown to be deletion Genotype, silk polymeric protein activity is more weak, skin
The easy shallow stricture of vagina of skin is too much；If T/T, then it it is normal genotype；
If SNP site rs3025058 of gene M MP3 is-/A, being shown to be deletion Genotype, enzyme is lived and is reduced, and increases collagen fiber
Damage and the risk destroyed, skin elasticity declines；If-/-, being then deletion Genotype, enzyme is lived and is reduced, and increases collagen fiber and damages
Wound and the risk destroyed, skin elasticity declines；If A/A, then it it is normal genotype；
If SNP site rs1799750 of gene M MP1 is C/C, being shown to be insertion genotype, enzyme is lived and is reduced, and increases collagen fiber
Damage and the risk destroyed, skin elasticity declines；If-/C, being shown to be insertion genotype, enzyme is lived and is reduced, and increases collagen fiber
Damage and the risk destroyed, skin elasticity declines；If-/-, then it it is normal genotype；
If SNP site rs1800255 of gene C OL3A1 is A/G, it is shown to be and carries heterozygous mutant, without relevant risk；If A/
A, is shown to be and carries homozygous mutation, and type III collagen protein weakens or disappears so that skin is more readily formed wrinkle；If G/G,
It it is then normal genotype.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610367685.2A CN105886645A (en) | 2016-05-27 | 2016-05-27 | Primer, probe and kit for evaluating anti-wrinkle condition of skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610367685.2A CN105886645A (en) | 2016-05-27 | 2016-05-27 | Primer, probe and kit for evaluating anti-wrinkle condition of skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105886645A true CN105886645A (en) | 2016-08-24 |
Family
ID=56708869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610367685.2A Pending CN105886645A (en) | 2016-05-27 | 2016-05-27 | Primer, probe and kit for evaluating anti-wrinkle condition of skin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105886645A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106435001A (en) * | 2016-12-07 | 2017-02-22 | 山东省皮肤病性病防治研究所 | Application of single nucleotide polymorphism rs146466242 to screening to leprosy patients |
| CN106498071A (en) * | 2016-11-14 | 2017-03-15 | 天津市康婷生物工程有限公司 | The system of skin skin quality is detected and is assessed from gene level |
| CN108018346A (en) * | 2018-01-15 | 2018-05-11 | 无锡中德美联生物技术有限公司 | Composite amplification reagent kit and its application of female skin and hair quality SNP genetic polymorphisms site are detected at the same time |
| CN108251521A (en) * | 2018-03-15 | 2018-07-06 | 北京天平永达科技发展有限公司 | For detecting the primer set of tumor susceptibility gene SNP related to skin aging and its application |
| CN109234406A (en) * | 2018-10-30 | 2019-01-18 | 深圳市万众基因转化医学研究院 | A kind of quick detection combination primer of mankind's skin quality and its application |
| CN109554480A (en) * | 2018-09-21 | 2019-04-02 | 广州益养生物科技有限公司 | Method for rapidly detecting hereditary skin elasticity gene |
| CN110904207A (en) * | 2019-06-14 | 2020-03-24 | 陕西九州医学检验有限公司 | A susceptibility gene detection panel related to skin aging characteristics and its application |
| CN114686578A (en) * | 2020-12-30 | 2022-07-01 | 北京本真工坊生物科技有限公司 | Skin type assessment method, application and system |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN203174095U (en) * | 2013-01-08 | 2013-09-04 | 百岳特生物科技（上海）有限公司 | Whitening and aging gene detection chip |
| WO2015131110A1 (en) * | 2014-02-27 | 2015-09-03 | Igenomx International Genomics Corporation | Methods for analysis of somatic mobile elements, and uses thereof |
| CN105603111A (en) * | 2016-03-29 | 2016-05-25 | 博奥颐和健康科学技术（北京）有限公司 | Application of SNP site of CNTN4 gene and detection primer and kit thereof |
-
2016
- 2016-05-27 CN CN201610367685.2A patent/CN105886645A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN203174095U (en) * | 2013-01-08 | 2013-09-04 | 百岳特生物科技（上海）有限公司 | Whitening and aging gene detection chip |
| WO2015131110A1 (en) * | 2014-02-27 | 2015-09-03 | Igenomx International Genomics Corporation | Methods for analysis of somatic mobile elements, and uses thereof |
| CN105603111A (en) * | 2016-03-29 | 2016-05-25 | 博奥颐和健康科学技术（北京）有限公司 | Application of SNP site of CNTN4 gene and detection primer and kit thereof |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106498071A (en) * | 2016-11-14 | 2017-03-15 | 天津市康婷生物工程有限公司 | The system of skin skin quality is detected and is assessed from gene level |
| CN106435001A (en) * | 2016-12-07 | 2017-02-22 | 山东省皮肤病性病防治研究所 | Application of single nucleotide polymorphism rs146466242 to screening to leprosy patients |
| CN106435001B (en) * | 2016-12-07 | 2019-09-06 | 山东省皮肤病性病防治研究所 | Application of the single nucleotide polymorphism rs146466242 in screening leper |
| CN108018346A (en) * | 2018-01-15 | 2018-05-11 | 无锡中德美联生物技术有限公司 | Composite amplification reagent kit and its application of female skin and hair quality SNP genetic polymorphisms site are detected at the same time |
| CN108251521A (en) * | 2018-03-15 | 2018-07-06 | 北京天平永达科技发展有限公司 | For detecting the primer set of tumor susceptibility gene SNP related to skin aging and its application |
| CN108251521B (en) * | 2018-03-15 | 2021-08-13 | 北京天平永达科技发展有限公司 | Complete set of primers for detecting susceptibility gene SNP related to skin aging and application thereof |
| CN109554480A (en) * | 2018-09-21 | 2019-04-02 | 广州益养生物科技有限公司 | Method for rapidly detecting hereditary skin elasticity gene |
| CN109234406A (en) * | 2018-10-30 | 2019-01-18 | 深圳市万众基因转化医学研究院 | A kind of quick detection combination primer of mankind's skin quality and its application |
| CN110904207A (en) * | 2019-06-14 | 2020-03-24 | 陕西九州医学检验有限公司 | A susceptibility gene detection panel related to skin aging characteristics and its application |
| CN110904207B (en) * | 2019-06-14 | 2022-07-29 | 陕西九州医学检验有限公司 | Susceptible gene detection panel related to skin aging characterization and application thereof |
| CN114686578A (en) * | 2020-12-30 | 2022-07-01 | 北京本真工坊生物科技有限公司 | Skin type assessment method, application and system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105886645A (en) | Primer, probe and kit for evaluating anti-wrinkle condition of skin | |
| CN105861719A (en) | Primer, probe and kit for evaluating skin anti-aging condition | |
| CN105886646A (en) | Primer, probe and kit for evaluating sun protection condition of skin | |
| US10685739B2 (en) | Personalized beauty system | |
| Peter et al. | Psychological resources, appraisals, and coping and their relationship to participation in spinal cord injury: a path analysis | |
| US20100062086A1 (en) | Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin | |
| US20070196344A1 (en) | Methods for identifying materials that can help regulate the condition of mammalian keratinous tissue | |
| CN105950738A (en) | Primer, probe and kit for evaluating skin anti-allergy condition | |
| JP5905121B2 (en) | Product selection using genetic analysis | |
| CN103201625A (en) | Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis | |
| US20120171133A1 (en) | Modulation of Dynein in Skin | |
| Iglesia et al. | A multi‐functional anti‐aging moisturizer maintains a diverse and balanced facial skin microbiome | |
| CN105803105A (en) | Primer, probe and kit for evaluating skin regeneration conditions | |
| Aleid et al. | Common allergens identified based on patch test results in patients with suspected contact dermatitis of the scalp | |
| US10758749B2 (en) | Cosmetic or dermatological composition and use thereof | |
| Haneke | Achilles foot-screening project: background, objectives and design | |
| US20180223365A1 (en) | Method for screening candidate compounds for preventing and/or attenuating skin aging, and/or for hydrating the skin | |
| CN105950737A (en) | Primer, probe and kit for evaluating skin defense condition | |
| CN105803106A (en) | Primer, probe and kit for evaluating skin moisturizing conditions | |
| Fritschi et al. | Risk factors for surgically treated benign prostatic hyperplasia in Western Australia | |
| KR102828498B1 (en) | Composition for wrinkle improvement comprising a retinol booster as an active ingredient | |
| CN110819723A (en) | Detection method for five gene combinations for assessing congenital skin quality and personalized skin care kit formulated according to detection results | |
| Yoo et al. | A genome-wide association study and machine-learning algorithm analysis on the prediction of facial phenotypes by genotypes in Korean women | |
| CN107875089A (en) | A kind of skin care item containing dendrobium candidum and its preparation method and application | |
| KR102610932B1 (en) | A composition for skin barrier function comprising CARD18 promoting materials and a method for screening CARD18 promoting materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |
|
| RJ01 | Rejection of invention patent application after publication |